That paper is not describing the use of dexamethasone in treating covid-19 respiratory syndrome. Your post, before I edited it, was dangerously close to politics and should not have been re-posted (unnecessarily) here. Consider yourself warned.
Jeremy
It doesn't mention covid-19 per se, but it does address a life-threatening complication of covid-19 that seems to be implcated in a large proportion of the fatality, so to pretend that the two are unrelated is not warranted.
https://www.health.com/condition/infectious-diseases/coronavirus/what-is-ardsThe majority of people—about 80% according to research—only suffer mild symptoms with COVID-19. Others may require hospitalization—but for some patients, the new coronavirus can be deadly.One life-threatening complication that can arise is acute respiratory distress syndrome, commonly referred to as ARDS. And new research from the JAMA Internal Medicine suggests that more than 40% of individuals in the study hospitalized for severe and critical COVID-19 developed ARDS—and over 50% of those diagnosed died from the disease.February - Spanish team publish paper showing efficacy of a drug in treatment of ARDS
February to June - lots of people with COVID19 die with ARDS
June - British team issue press release showing efficacy of drug in treating patients with COVID19.